Czechia Pharmaceutical and Medical Goods Expenditure Share
Czechia Pharmaceutical and Medical Goods Expenditure Share published by Eurostat, covering Czechia at annual frequency (2005–2023).
Czechia (2023)
16.2
% of current health expenditure
+0.0pp YoY
YoY Change
+0.0pp
percentage points
Trend
neutral
Series length
14
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 16.2 | +0.0pp |
| 2022 | 16.1 | +0.5pp |
| 2021 | 15.7 | -1.9pp |
| 2020 | 17.6 | -0.7pp |
| 2019 | 18.3 | -0.6pp |
| 2018 | 18.9 | -0.8pp |
| 2017 | 19.7 | -0.7pp |
| 2016 | 20.4 | -0.5pp |
| 2015 | 20.9 | -0.2pp |
| 2014 | 21.1 | -0.8pp |
| 2013 | 21.9 | -0.8pp |
| 2012 | 22.8 | +0.2pp |
| 2011 | 22.6 | +0.1pp |
| 2010 | 22.5 | n/a |
About this Dataset
Czechia recorded 16.2 % of current health expenditure in 2023. The most recent year-on-year change was +0.0pp. The historical series (2005–2023) shows a peak of 22.8 in 2012 and a trough of 15.7 in 2021.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology ensuring cross-country comparability within the European statistical framework.
The chart above shows the full historical trend; the table below lists annual values with year-on-year changes.
Frequently Asked Questions
This indicator tracks czechia pharmaceutical and medical goods expenditure share in Czechia, published by Eurostat. Data covers 2005–2023 at annual frequency using harmonised methodology.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. Data is updated annual.
The series peaked at 22.8 % of current health expenditure in 2012 and reached its lowest recorded value of 15.7 in 2021. The latest reading of 16.2 in 2023 represents a year-on-year change of +0.0pp.